2011
DOI: 10.1016/j.oraloncology.2011.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Adjuvant radiotherapy and health-related quality of life of patients at intermediate risk of recurrence following primary surgery for oral squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
25
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 29 publications
0
25
0
Order By: Relevance
“…Despite the heterogeneity of the designs, the results/conclusions are on the same line: a decrease in the HRQoL after treatment (14-22), which appears to parallel the magnitude of the tumor (2,4,23-31), and the use of radiotherapy (2,4,5,29,32-40). After a year, this declining trend turns around (15,16,18,20,22,41-47).…”
Section: Discussionmentioning
confidence: 93%
“…Despite the heterogeneity of the designs, the results/conclusions are on the same line: a decrease in the HRQoL after treatment (14-22), which appears to parallel the magnitude of the tumor (2,4,23-31), and the use of radiotherapy (2,4,5,29,32-40). After a year, this declining trend turns around (15,16,18,20,22,41-47).…”
Section: Discussionmentioning
confidence: 93%
“…There is a paucity of high‐level evidence to base recommendations for prescription of PORT for OSCC . Despite the widespread use of PORT since its introduction by Maccomb and Fletcher in 1957, only 3 randomized trials exist in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…This group includes node‐negative patients with close margins or adverse pathological features at the primary site, and patients with a single positive node without ECS . There is no consensus as to which of these patients will benefit from PORT and the potential for reduced recurrence must be balanced against the significant local toxicity …”
Section: Introductionmentioning
confidence: 99%
“…12 Certain items were very common and impact across all patients in respect to their cancer treatment. 18 It is important to encourage patients to talk about these items as there are interventions available. It is appropriate to advocate treatments that minimize xerostomia as a side effect, such as the use of IMRT.…”
Section: Patient Concerns Inventorymentioning
confidence: 99%